Ratio Between Metastatic and Examined Lymph Nodes Is an Independent Prognostic Factor After D2 Resection for Gastric Cancer: Analysis of a Large European Monoinstitutional Experience

[1]  F. Roviello,et al.  The new TNM classification of lymph node metastasis minimises stage migration problems in gastric cancer patients , 2002, British Journal of Cancer.

[2]  S. Choi,et al.  Prognostic Significance of Metastatic Lymph Node Ratio in T3Gastric Cancer , 2002, World Journal of Surgery.

[3]  Scott A. Hundahl,et al.  Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction. , 2001, The New England journal of medicine.

[4]  J. Ajani,et al.  A Pilot Study of Preoperative Chemoradiotherapy for Resectable Gastric Cancer , 2001, Annals of Surgical Oncology.

[5]  S. Weeden,et al.  Patient survival after D1 and D2 resections for gastric cancer: long-term results of MRC randomized surgical trial , 2001 .

[6]  D. Klimstra,et al.  Lymph Node Staging in Gastric Cancer: Is Location More Important Than Number?: An Analysis of 1,038 Patients , 2000, Annals of surgery.

[7]  P. Hermanek.  The superiority of the new International Union Against Cancer and American Joint Committee on Cancer TNM staging of gastric carcinoma , 2000, Cancer.

[8]  H. Katai,et al.  Evaluation of the new international union against cancer TNM staging for gastric carcinoma , 2000, Cancer.

[9]  S. Hundahl,et al.  The National Cancer Data Base report on poor survival of U.S. gastric carcinoma patients treated with gastrectomy , 2000, Cancer.

[10]  Y. Sugiyama,et al.  A comparison of the prognostic significance between the number of metastatic lymph nodes and nodal stage in gastric carcinoma. , 1999, Hepato-gastroenterology.

[11]  H. Meyer,et al.  Lymph node dissection for gastric cancer. , 1999, Seminars in surgical oncology.

[12]  D. Gouma,et al.  Extended lymph-node dissection for gastric cancer. , 1999, The New England journal of medicine.

[13]  J. Siewert,et al.  Relevant prognostic factors in gastric cancer: ten-year results of the German Gastric Cancer Study. , 1998, Annals of surgery.

[14]  Y. Kodera,et al.  Lymph node status assessment for gastric carcinoma: Is the number of metastatic lymph nodes really practical as a parameter for N categories in the TNM classification? , 1998, Journal of surgical oncology.

[15]  M. Sasako.  Risk factors for surgical treatment in the Dutch gastric cancer trial , 1997, The British journal of surgery.

[16]  G. Choi,et al.  Comparison of five systems for staging lymph node metastasis in gastric cancer , 1997, The British journal of surgery.

[17]  A. Stewart,et al.  Gastric carcinoma: does lymph node dissection alter survival? , 1996, Journal of the American College of Surgeons.

[18]  M. Coleman,et al.  Survival of cancer patients in europe—The EUROCARE study , 1995, Cancer Causes & Control.

[19]  J. Chmiel,et al.  Cancer of the stomach. A patient care study by the American College of Surgeons. , 1993, Annals of surgery.

[20]  Siewert,et al.  Prognostic relevance of systematic lymph node dissection in gastric carcinoma , 1993, The British journal of surgery.

[21]  M. Rothmund,et al.  Lymph node counts in the upper abdomen: Anatomical basis for lymphadenectomy in gastric cancer , 1991, The British journal of surgery.

[22]  P. Grambsch,et al.  Martingale-based residuals for survival models , 1990 .

[23]  B. Bodner.  Will Rogers and gastric carcinoma. , 1988, Archives of surgery.

[24]  A R Feinstein,et al.  The Will Rogers phenomenon. Stage migration and new diagnostic techniques as a source of misleading statistics for survival in cancer. , 1985, The New England journal of medicine.

[25]  Tanaki Kajitani,et al.  The general rules for the gastric cancer study in surgery and pathology , 1981, The Japanese journal of surgery.

[26]  E. Kaplan,et al.  Nonparametric Estimation from Incomplete Observations , 1958 .

[27]  Kentaro Inoue,et al.  The superiority of ratio-based lymph node staging in gastric carcinoma , 2002, Annals of Surgical Oncology.

[28]  J. Mezger.  [Neoadjuvant and adjuvant chemotherapy of locally advanced stomach cancer]. , 2001, Onkologie.

[29]  M. Huguier,et al.  [Extended lymph-node dissection for gastric cancer]. , 1999, Chirurgie; memoires de l'Academie de chirurgie.

[30]  Japanese Gastric Cancer Association.  Japanese Classification of Gastric Carcinoma – 2nd English Edition – , 1998, Gastric Cancer.

[31]  C. Compton,et al.  Protocol for the examination of specimens removed from patients with gastric carcinoma: A basis for checklists , 1998 .

[32]  G. Fleuren,et al.  Surgical/pathologic-stage migration confounds comparisons of gastric cancer survival rates between Japan and Western countries. , 1995, Journal of Clinical Oncology.

[33]  D.,et al.  Regression Models and Life-Tables , 2022 .